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Abstract
Background: In Enterococcus faecalis the genes encoding the enzymes involved in citrate metabolism are
organized in two divergent operons, citHO and oadHDB-citCDEFX-oadA-citMG (citCL locus). Expression of both
operons is specifically activated by adding citrate to the medium. This activation is mediated by binding of the
GntR-like transcriptional regulator (CitO) to the cis-acting sequences located in the cit intergenic region. Early
studies indicated that citrate and glucose could not be co-metabolized suggesting some form of catabolite
repression, however the molecular mechanism remained unknown.
Results: In this study, we observed that the citHO promoter is repressed in the presence of sugars transported by
the Phosphoenolpyruvate:carbohydrate Phosphotranserase System (PTS sugars). This result strongly suggested that
Carbon Catabolic Repression (CCR) impedes the expression of the activator CitO and the subsequent induction of
the cit pathway. In fact, we demonstrate that CCR is acting on both promoters. It is partially relieved in a ccpA-
deficient E. faecalis strain indicating that a CcpA-independent mechanism is also involved in regulation of the two
operons. Furthermore, sequence analysis of the citH/oadH intergenic region revealed the presence of three
putative catabolite responsive elements (cre). We found that they are all active and able to bind the CcpA/P-Ser-
HPr complex, which downregulates the expression of the cit operons. Systematic mutation of the CcpA/P-Ser-HPr
binding sites revealed that cre1 and cre2 contribute to citHO repression, while cre3 is involved in CCR of citCL
Conclusion: In conclusion, our study establishes that expression of the cit operons in E. faecalis is controlled by
CCR via CcpA-dependent and -independent mechanisms.
Background
Lactic acid bacteria (LAB) are widely used in food indus-
try due to their capacity to convert sugar into lactic acid.
However, they can also metabolize other organic com-
pounds present in the raw material utilized for food fer-
mentation. Citrate metabolism has been extensively
studied in LAB from the applied point of view, since this
fermentation leads to the production of diacetyl. This
compound is the most broadly used butter flavor in dairy
industry [1,2] and also contributes to the quality of wine
[3].
In LAB, the genes involved in citrate fermentation are
usually organized in two operons [4-6]. In these operons,
the organization of the genes encoding the holoenzyme of
the citrate lyase complex (citD, citE and citF) is extremely
well conserved. The clusters also have the accessory genes
required for the synthesis and activation of citrate lyase
(citC, citG and citX). Two different families of citrate
transporters associated to LAB cit operons have been
characterized [for review see reference [7]]. The 2HCT (2-
hydroxycarboxylate) transporter family includes the
citrate/lactate exchanger CitP found in Lactococcus lactis
and Weissella paramesenteroides [8], while the proton-
coupled citrate-Me
2+ symporter of the CitMHS family
includes CitH from Enterococcus faecalis [9].
We also contributed to the identification of two differ-
ent oxaloacetate decarboxylases (OAD) linked to the
LAB cit cluster, i) soluble citM [10,11] and ii) the
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which in E. faecalis includes also the novel subunit OadH
[6].
Finally, two different transcriptional regulators are
involved in the activation of the cit operons in LAB: CitI
and CitO. CitI belongs to the SorC/DeoR family, and its
role in the activation of the cit operons was previously
established in W. paramesenteroides [4,12]. CitI acts in the
presence of citrate as an activator, recognizing and binding
to two operator sites located in the intergenic region on
the cit operons [4,12]. CitO, a member of the GntR family,
was recently described as the activating factor required for
the induction of genes encoding the enzymes involved in
citrate metabolism in E. faecalis. This activation is
mediated by binding of CitO to the cis-acting sequences
located in the cit intergenic region (O1 and O2) in the
presence of citrate [6].
Citrate fermentation by Enterococcus is relevant, since
this group of microorganisms is frequently isolated from
the microflora of artisanal cheese [13]. They contribute to
cheese ripening and development of their aroma [2]. Early
studies [14] showed that E. faecalis could co-metabolize
lactose and citrate in milk containing yeast extract but
could not co-metabolize glucose and citrate in a complex
medium. Rea and Cogan analyzed the factors affecting
citrate metabolism and found that it was inhibited by the
presence of glucose in several E. faecalis and E. faecium
strains [15]. However, the mechanism of glucose-mediated
repression of citrate metabolism is poorly understood.
In Firmicutes, the global mechanism of CCR is mediated
by the pleiotropically acting transcription factor CcpA [for
a review see reference [16,17]]. The ability of CcpA to
bind its target sites, the catabolite responsive elements
(cre), is in turn controlled by the presence of its corepres-
sor, serine-phosphorylated HPr (P-Ser-HPr) [18,19]. HPr
has been purified from E. faecalis [20] and the structures
of unphosphorylated [21] and serine-phosphorylated
HPr [22] have been determined. Like HPr from other
Firmicutes,t h eE. faecalis protein can be phosphorylated
at histidine-15 using phosphorylated Enzyme I as phos-
phate-donor and/or at serine-46 by an ATP-dependent
HPr kinase, with the former modification slowing the
phosphotransfer to sugar-specific Enzyme IIs [23]. The
ATP-dependent HPr kinase gene has been cloned from
E. faecalis [ 2 4 ]a n de x p r e s s e di nEscherichia coli.T h e
enzyme is bifunctional and acts either as ATP-dependent
HPr kinase when bacteria are grown on efficiently used
carbon sources or as a P-Ser-HPr dephosphorylating, pyr-
ophosphate-forming phosphorylase when the concentra-
tion of ATP and glycolytic intermediates is low. Only
P-Ser-HPr, but none of the other HPr forms, is able to
form a complex with CcpA active in CCR [19,25].
The results presented in this manuscript suggest a
strong repression of the expression of the cit operons in
E. faecalis exerted by CCR. We identified multiple cre
sites located in the citH/oadH intergenic region.
Furthermore, our results demonstrate that transcrip-
tional repression of the citrate transporter (citH)a n d
the transcription factor (citO) are caused by the pre-
sence of two cre sites organized in tandem (cre1
and cre2), whereas control of the catabolic operon
oadHDB-citCDEFX-oadA-citMG (citCL locus) requires
an independent cre site (cre3). Our studies revealed PTS-
mediated CCR mechanisms of the cit operons that are
partly CcpA-dependent and partly CcpA-independent.
Results
Catabolite repression of the cit operons occurs in the
presence of PTS-sugars
We recently described that the molecular mechanism
underlying activation of the cit operons (citHO and citCL)
in E. faecalis requires the transcriptional factor CitO [6].
Rea and Cogan had previously suggested that glucose
represses citrate metabolism in this bacterium [15]. We
therefore studied whether different carbon sources might
affect transcription of the genes involved in citrate utiliza-
tion. To accomplish this task, we measured the activity of
the cit promoters (PcitHO and PcitCL, Figure 1A) by fus-
ing them to the promoterless lacZ gene in the vector
pTCV-lac [26]. b-Galactosidase activity was determined in
cell extracts of E. faecalis JH2-2 harboring plasmid pTCV-
PcitHO or pTCV-PcitCL, constructed in a previous work
by Blancato et al., 2008 (strains JHB2 and JHB6, Table 1)
[6].
First, we studied the effect of the presence of PTS or
non-PTS sugars on the expression of both transcriptional
fusions in the wild type strain. As shown in Figure 1B,
when cells were grown in LB medium containing 1%
citrate (LBC) expression of both promoters were active.
When non-PTS sugars (raffinose, galactose or arabinose)
where added to LBC medium, no repression on the cit
operons was observed. However, when a PTS sugar was
added (glucose, lactose, fructose, maltose, trehalose or cel-
lobiose) to the LBC medium, we found a significant repres-
sion of b-galactosidase activity and hence of transcription
from both cit promoters (93 to 99% of repression) (Figure
1B), which suggests a general CCR mechanism.
CcpA is controlling citOH and citCL expression
Because CCR of the cit operons was mainly elicited by
PTS sugars, it was likely that it followed the general CCR
mechanism of Firmicutes, which is mediated via the
DNA-binding protein CcpA, the corepressor P-Ser-HPr
and a cis-acting sequence (cre). We first tested the invol-
vement of CcpA in repression of transcription from the
PcitHO and PcitCL enterococcal promoters. To this end,
the activity of the cit promoters was measured in a
CcpA-deficient E. faecalis strain (CL14) [27] containing
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Page 2 of 13either the pTCV-PcitHO or the pTCV-PcitCL plasmid
(strains CL1 and CL2, respectively) (Figure 1C). b-Galac-
tosidase activity was determined in cell extracts of E. fae-
calis grown in LBC supplemented with the same PTS
and non-PTS sugars, described in Figure 1B. As shown in
Figure 1C, no significant repression was observed in the
presence of non-PTS sugars and PTS sugars exerted a
much weaker repressive effect than in the wild-type
strain. However, in these CcpA-defective E. faecalis
strains the repression was not completely alleviated.
A similar observation was reported for other genes con-
trolled by the CCR in E. faecalis [27].
Subsequently, we tested whether expression of the cit
operons depends on the glucose concentration. Hence, we
measured the b-galactosidase activity in wild-type and ccpA
mutant strains carrying either one of the two transcrip-
tional cit promoter-lacZ fusions. In the wild-type-derived
strains (JHB2 and JHB6) b-galactosidase activity decreased
when the initial concentration of glucose was raised
from 0.25 to 1% (Figure 2A). On the other hand, in the
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Figure 1 Effect of different sugars on expression of the cit operons. A) Genetic organization of E. faecalis cit metabolic operons. PcitHO,
promoter of the citHO operon composed of CitH (Me
2+-citrate transporter) and CitO (GntR transcriptional regulator); PcitCL promoter of the citCL
operon composed of OadHDBA (oxaloacetate decarboxylase membrane complex), CitCDEFXG (citrate lyase and accessory proteins) and CitM
(soluble oxaloacetate decarboxylase). O1 and O2 binding sites of the activator CitO. B and C) Influence of diverse PTS and non-PTS sugars on the
expression of PcitHO-lacZ and PcitCL-lacZ fusions. JHB2 (JH2-2/pTCV-PcitHO), JHB6 (JH2-2/pTCV-PcitCL), CL1 (CL14/pTCV-PcitHO) and CL2 (CL14/
pTCV-PcitCL) were grown in LBC and LBC supplemented with 30 mM initial concentration of different sugars. Levels of accumulated b-
galactosidase activity were measured 7 h after inoculation. Error bars represent standard deviation of triplicate measurements.
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Page 3 of 13CcpA-deficient strains (CL1 and CL2) activity of the cit
promoters was independent of the glucose concentration
(Figure 2B). These results suggest that the activity of the cit
promoters is tightly regulated by the availability of glucose
and that the pleiotropic transcriptional factor CcpA is
involved in this process.
In order to determine whether these differences in
transcriptional repression affect the level of the proteins
encoded by the cit operons, the amounts of CitO and
citrate lyase activity were determined. First, a Western
blot using antibodies raised against purified CitO was
performed with extracts of wild type E. faecalis JH2-2
grown during 7 hs in LBC supplemented with different
initial concentrations of gl u c o s e( 0 . 2 5 % ,0 . 5 %o r1 % ) .A
gradual decrease of the intensity of the CitO-specific
band accompanied the increase of the glucose concentra-
tion (Figure 2C, left panel; lanes 1 to 4). Next, an identi-
cal experiment was carried out with the CcpA-deficient
strain (CL14) as depicted in Figure 2C (right panel). In
this case, CitO levels remained constant despite the
increase of the glucose concentration. We also deter-
mined PcitCL repression by measuring the citrate lyase
activity in cell extracts. Maximal citrate lyase activity was
measured in the wild type JH2-2 strain grown in LB sup-
plemented with 1% citrate (Figure 2D, left panel). How-
ever, activity diminished when glucose was added to LBC
medium, with maximal repression reached at 1% glucose
(90% of repression). Citrate lyase activity was also mea-
sured in the CcpA-deficient strain CL14 grown under
conditions identical to those used for JH2-2. Only 40%
repression was observed in this case, with no significant
difference between the activities measured at the differ-
ent glucose concentrations.
Both cit operons are under the direct control of CCR
The divergent organization of the cit g e n e sr a i s e st h e
possibility that the CCR observed could be accomplished
by repressing the positive regulator of the pathway
(CitO) and the citrate uptake (mediated by CitH). To
address this question, CitO was expressed in trans
autonomously of the PcitHO promoter (strain JHB11)
[6]. In that strain we used the pBM02-derived [28] plas-
mid, pCitO, in which the expression of citO is under the
control of the lactococcal Pcit promoter. As described
by Marelli et al., 2010 [28], in E. faecalis expression of
different genes put under control of the Pcit promoter
was constitutive. In the JHB11-derived strains JHB15
and JHB16 (carrying plasmids pTCV-PcitHO and
pTCV-PcitCL, respectively) the activity of the promoters
was determined. From Figure 3A it can be seen that in
the JHB15 strain repression occurred over the complete
range of glucose concentrations tested, whereas in the
JHB16 strain (Figure 3B) repression was only noticeable
at higher initial glucose concentrations (0.5% (up-point-
ing triangle) and 1% (down-pointing triangle)). Western
blot analysis indicated that CitO levels remained con-
stant in strain JHB11 independently of whether it was
grown in presence of citrate (1%) or citrate (1%) and
glucose (1%) (Figure 3C). The results presented in Fig-
ure 3 suggest that repression of PcitCL is directly
mediated by CcpA and that repression of PcitHO is
stronger than repression of PcitCL since PcitHO but not
PcitCL was repressed at 0.25% initial glucose.
Multiple cre sites mediate the CCR of the cit operons
The results presented up to this point show that PTS
sugars repress the citrate fermentation pathway through
the action of CcpA. A bioinformatic search in the diver-
gent promoter region revealed the presence of three
putative catabolite responsive elements (cre sites) highly
homologous to the E. faecalis consensus cre site [TG(T/
A)NANCGNTN(T/A)CA] [27] and [(T/A)TG(T/A)AA
(A/G)CG(C/T)(T/A)(T/A) (T/A)C(T/A)] [29]. cre1 (C1)
and cre2 (C2) are located downstream from PcitHO;C 1
is located in the coding region of citH and C2 in the
untranslated region at 207-bp and 94-bp, respectively,
downstream from the transcriptional start site (TSS) of
the citHO operon (distances are indicated relative to the
center of symmetry). cre3 (C3) is located 97-bp down-
stream from the citCL TSS within the coding region of
oadH (Figure 4).
To address the question whether these putative cre
sites were recognized by E. faecalis CcpA, a His6-CcpA
fusion protein was overproduced in E. coli. The purified
fusion protein was used in gel mobility shift assays using
Table 1 E. faecalis strains used in this study
Strain Genotype or description Source or reference
JH2-2 Cit+ [44,45]
CL14 CcpA deficient [27]
JHB1 JH2-2 citO::pmCitO [6]
JHB2 JH2-2 (pTCV-PcitHO)[ 6 ]
JHB6 JH2-2 (pTCV-PcitCL)[ 6 ]
CL1 CL14 (pTCV-PcitHO) This study
CL2 CL14 (pTCV-PcitCL) This study
JHB11 JHB1 (pCitO) [6]
JHB15 JHB1 (pTCV- PcitHO) (pCitO) [6]
JHB16 JHB1 (pTCV- PcitCL) (pCitO) [6]
JHS1 JHB11 (pTCV-PcitHO-C1C2) This study
JHS2 JHB11 (pTCV-PcitHO-C1C2M) This study
JHS3 JHB11 (pTCV-PcitHO-C2C3) This study
JHS4 JHB11 (pTCV-PcitHO-C2MC3) This study
JHS5 JHB11(pTCV-PcitHO-C2MC3M) This study
JHS6 JHB11 (pTCV-PcitCL-C2C3) This study
JHS7 JHB11 (pTCV-PcitCL-C2C3M) This study
JHS8 JHB11(pTCV-PcitCL-C2MC3M) This study
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Figure 2 Effect of glucose concentrations on the expression of cit operons, CitO levels and citrate lyase activity. A and B) JHB2 (JH2-2/
pTCV-PcitHO), JHB6 (JH2-2/pTCV-PcitCL), CL1 (CL14/pTCV-PcitHO) and CL2 strains (CL14/pTCV-PcitCL) were grown in LBC (circle) or LBC
supplemented with different initial concentrations of glucose: 0.25% (square), 0.5% (up-pointing triangle) and 1% (down-pointing triangle). The
corresponding open symbols indicate the remaining glucose concentration in the culture medium (right axis). Levels of accumulated b-
galactosidase activity were measured at different times as indicated in the figure. C and D) E. faecalis strains were grown in the same conditions
of panels A and B, and cells extracts were obtained 7 h after inoculation, C) Western blot analysis was performed with polyclonal antibodies
raised against CitO. D) Citrate lyase activity was determined as described previously [5]. Error bars represent standard deviation of triplicate
measurements.
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Page 5 of 13DNA fragments corresponding to the individual cre
sites. The cre amplicons were exposed to increasing
concentrations of purified CcpA and a fixed concentra-
tion of HPr or P-Ser-HPr. FBP was also included in the
reaction buffer since its addition enhanced CcpA bind-
ing to cre sites (not shown). As shown in Figure 4,
CcpA without its corepressor did not bind to the cre
sites under the conditions employed; including HPr in
the assay solution did not lead to detectable CcpA-DNA
interaction. However, the combination of CcpA with its
corepressor P-Ser-HPr resulted in the formation of one
retarded complex for each amplicon (Figure 4B, lanes 8
and 9; C, lanes 12-15 and D, lanes 8 and 9). The binding
specificity was confirmed by determining that CcpA did
not bind to mutated amplicons (Bm and Cm), in which
the cre site was changed to TaTAcGatTgAAtc (lower-
case letters indicate mismatches with the consensus
sequence) (Figure 4C, lanes 16 and 17; D, Lanes 10 and
11). A comparison of the binding pattern suggests that
the P-Ser-HPr-CcpA complex possesses a 10-fold higher
affinity for cre site C2 than for C1 or C3, since with
0.05 μM CcpA it is possible to observe the formation of
a retarded complex (Figure 4C, lane 12) whereas binding
to C1 or C3 required a concentration of 0.5 μMC c p A
(lane 8 in Figure 4B and 4D, respectively).
In order to test the role of these sites in the transcrip-
tion regulation mechanism mediated by CcpA, a set of
DNA fragments corresponding to altered cit promoter
regions (i.e. cre sites deleted or mutated) were fused to
the promoterless lacZ reporter gene of the pTCV-lac
vector (Figure 5). Plasmids harboring the Pcit-lacZ tran-
scriptional fusions were electroporated into the E. faeca-
lis JHB11 strain.
We used this strain, in which citO is under the control of
the constitutive L. lactis promoter Pcit, in order to deter-
mine the specific repression mediated by CcpA interacting
with the cre sites. Accumulated b-galactosidase activity was
measured in the JHB11-derived strains grown in the pre-
sence of only citrate or of both the inducer citrate and the
repressor glucose. In Figure 5, b-galactosidase activities
determined 7 hs after inoculation are expressed as glucose
repression index (ri = MULBC/MULBCG,w h e r eM U LBC and
MULBCG represent the b-galactosidase activities measured
in cells grown in the absence or presence of glucose,
AB
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Figure 3 Effect of different glucose concentrations on the expression of cit promoters in a CitO constitutive genetic background.A
and B) JHB15 (JHB11/pTCV-PcitHO) and JHB16 strains (JHB11/pTCV-PcitCL) were grown in LBC (circle) or LBC supplemented with different initial
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1% (LBC) or citrate 1% plus glucose 1% (LBCG).
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Page 6 of 13respectively). We first studied the effect of alterations in the
multiple cre sites on expression from the citHO promoter.
A comparison of the glucose repression index for the tran-
scriptional fusion in strain JHS1, where cre sites 1 and 2
are present, with that determined for strain JHS2 contain-
ing only functional C1, revealed no significant difference
(ri: 20.0 ± 1.0 vs 17.2 ± 2.0) (Figure 5). When C1 was
deleted from the citHO promoter region we found that C2
was still capable of causing CCR on the citHO promoter,
but with a slightly lower repression index (ri: 11.5 ± 0.2)
(Figure 5, strain JHS3). In contrast, when the C2 site was
mutated (strain JHS4) the glucose repression index
dropped more than 4-fold compared with strain JHS3 (ri:
2.6 ± 0.6).
We subsequently studied whether the role of C3 in
the repression of PcitCL. The glucose repression index
(ri: 11.1 ± 1.0) measured for strain JHS6 indicates that it
is submitted to CCR. This repression was diminished in
strain JHS7 lacking C3 in the PcitCL promoter region
(Figure 5).
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Figure 4 Binding of CcpA to DNA fragments containing different cre sites. A) Nucleotide sequence of the citH-oadH intergenic regions.
Locations of transcription start sites are indicated (+1); -10 and -35; regions are shown underlined. Arrows indicate direction of transcription and
translation. CitO binding sequences are displayed in dotted boxes and putative cre sites in grey boxes. B, C and D) Images of gel shift assays
performed with different amplicons (A, B and C respectively) covering each cre site or mutated cre site amplicons (Bm and Cm), increasing
concentrations of CcpA and fixed concentrations of HPr or P-Ser-HPr.
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repression, since the presence or absence of C3 had no
effect on the repression of this promoter (strains JHS4 and
JHS5). Moreover, C2 had no influence on PcitCL repres-
sion because deletion of C2 did not produce a significant
difference in the glucose repression index of strains JHS7
(C2 present) and JHS8 (C2 deleted) (Figure 5).
Altogether, these results indicate that cre1 and cre2
are responsible for CCR of the citHO operon, and cre3
is the cis-acting sequence responsible of the repression
of the citCL operon.
Discussion
In this work we demonstrate that citrate metabolism in
E. faecalis is under the control of the general carbon
catabolic repression mechanism and elucidate the details
of the CcpA/P-Ser-HPr-dependent molecular mechan-
ism. Clearly, our results establish that CcpA-dependent
and -independent mechanisms are involved in CCR of
the cit operons depending on the repressing sugar
employed.
We found that the global transcriptional factor CcpA
exerts transcriptional regulation via the three active cre
sites which allows controlling the expression of the
citHO operon as well as the catabolic operon citCL. Band
shift assays showed that the P-Ser-HPr-CcpA complex
has a higher affinity for cre site C2 than for C1 or C3.
Miwa et al. analyzed several cre sites from B. subtilis and
concluded that strong similarity of cre sequences to the
consensus sequence favors a physiological role and that a
more extended palindrome of cre sequences correlates
with stronger repression [30]. Remarkably, Schumacher
et al. recently established that P-Ser-HPr-CcpA complex
binds to different cres with similar affinities. However, it
is important to note that this analysis was performed
with P-Ser-HPr-CcpA interacting only with cre sites
belonging to different operators [31]. The difference in
affinity that we observed between C1, and C2 or C3
might therefore be related to the surrounding sequences
of the cre r e g i o n[ 3 2 ] .T h i sa l s om i g h te x p l a i nw h yC 2 ,
although having the highest affinity for CcpA, seems not
to be the dominant cre in repression.
Interestingly, analysis of the effect of different PTS
sugars on the cit operons showed significant differences.
The presence of lactose in the growth medium produced
a strong repressive effect which was completely relieved
O1 O2
PcitHO PcitCL
Glucose
Repression
index
(MU /MU ) LBC LBCG
11.1 ± 1.0
4.0 ± 0.2
11.5 ± 0.2 JHS3
2.6 ± 0.6 JHS4
lacZ
17.2 ± 2.0
JHS1 20.0 ± 1.0 
JHS2
JHS5
JHS6
Transcriptional fusion Strain
C1 C2
lacZ M C1
lacZ M M C2
lacZ C2 C3
lacZ C2 C3
lacZ M M
lacZ M M M
2.5 ± 0.3 
4.8 ± 1.2 
lacZ M C3
JHS7
JHS8
Figure 5 Schematic representation of the pTCV-lac derived plasmids. Promoter regions of the citHO and citCL operons are shown. The
different cre sites are indicated by boxes (C1,C 2,C 3 and M for mutated cre sites). The glucose repression index represents the ratio of
accumulated b-galactosidase activity between cell extracts from cultures grown in LBC and LBCG medium (MULBC/MULBGC) for 7 hours.
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Page 8 of 13in the CcpA deficient strain. However, with other PTS
s u g a r s ,s u c ha sg l u c o s e ,t h i sr e p r e s s i v ee f f e c tw a so n l y
partially relieved in the CcpA-defective strain. This result
suggests that lactose repression of the cit operons is
exclusively mediated via CcpA, whereas for the other
sugars CcpA-independent mechanisms seem to exist.
This observation prompted us to look for alternative PTS
repression mechanisms involved in CCR observed in the
cit operons. First, we searched for phosphorylatable
domains in the transcriptional regulator CitO that could
regulate its activator function in response to their phos-
phorylation state [33]. A domain search analysis of the
amino acid sequence by means of InterProScan Sequence
Search [34] revealed that CitO does not possess neither
PRDs nor EIIA or HPr domains. We also dismissed indu-
cer exclusion as possible mechanism of CcpA-indepen-
dent repression because the E. faecalis strain grown in
LB in the presence of citrate and glucose maintained the
ability to incorporate [
14C]-citrate (data not shown).
Interestingly, Zeng et al. suggested that there is a direct
involvement of P-Ser-HPr and the glucose/mannose-PTS
EIIAB
Man (ManL) in CCR of the fructan hydrolase
(fruAB)a n dt h elevDEFGX operons [35]. Furthermore,
Opsata et al.s h o w e dt h a ti na nE. faecalis V583 mutant
strain with strong reduction in expression of the man-
nose PTS operon, the citE gene was upregulated 5-fold
when compared with the wild type grown in BHI med-
ium (which contains glucose and citrate, among other
components) [29]. We constructed a JH2-2-derived man-
nose PTS deficient strain and a ccpA PTS
Man double
mutant. Unfortunately, we could not find an apparent
correlation between the activity of the promoters in the
presence of citrate (LBC) and glucose plus citrate. Finally,
homologs to CcpN (EF1025) and YqfL (EF2419) were
found in the E. faecalis genome. These regulators are
involved in CcpA-independent CCR in B. subtilis [36]
and their direct or indirect participation in the regulation
of the cit operons cannot be ruled out. Recent publica-
tions using transcriptome analysis suggested that the cit
operons might be regulated by Rex (a regulator respond-
ing to NAD/NADH ratio) [37] and indirectly by Ers (a
PrfA-like regulator) [38]. Nevertheless, their contribution
to the regulation in the presence of citrate and PTS
sugars remains to be determined. Although convincing
evidence for a CcpA-independent mechanism of repres-
sion is presented in this work, more experiments will be
necessary to elucidate it at the molecular level.
One question which arose from our studies was why
does E. faecalis regulate citrate transport and metabo-
lism in such a strict way? In Bacillus subtilis,c i t r a t e
uptake interferes directly with the regulation of the
Krebs cycle enzymes, which explains why expression of
the transporter is tightly controlled [39]. However,
citrate transport by enterococcal cells will not cause an
imbalance of metabolites of the TCA because E. faecalis
lacks most of the enzymes of the Krebs cycle. Neverthe-
less, like B. subtilis, E. faecalis transports citrate com-
plexed with a well-defined set of bivalent metal ions:
Ca
2+,S r
2+,M n
2+,C d
2+,a n dP b
2+ [9]. The ability to take
up toxic bivalent metal ions in complex with citrate
might render E. faecalis sensitive to the toxic heavy
metal ions in citrate-containing medium. It is possible
that the sophisticated regulation of cit gene expression
allows E. faecalis to resist and persist in different envir-
onments and to synthesize in controlled form the
enzymes necessary for the transport and metabolism of
the nutrients in order to optimize its growth.
Conclusions
In conclusion, this study shows that citrate metabolism
in E. faecalis is controlled by general Carbon Catabolic
Repression. We found that CcpA exerts the transcrip-
tional regulation through three active cre sites which
allows control of the expression of the citHO operon as
well as the catabolic operon citCL. Thus, this complex
regulatory mechanism ensures the control not only of
the transcriptional factor citO but also of the citrate
transporter citH, which reduces the uptake of the indu-
cer required by the activator. An extra control point was
found in the citCL operon which fine-tunes the levels of
degradative enzymes encoded by this operon. Also, we
found that an independent mechanism of CCR is opera-
tive on the citrate operons in this bacterium. All these
results contribute to understand how E. faecalis controls
the hierarchical use of the carbon source that allows it
to survive in different habitats and growth conditions.
Methods
Bacterial strains and growth conditions
Cultures of E. faecalis were grown at 37°C without shaking
in 100 ml sealed bottles containing 20-50 ml of Luria-Ber-
tani medium (LB) [40], supplemented with 1% trisodium
citrate (LBC) or different carbon sources as indicated with
an initial pH of 7.0. The growth medium was supplemen-
ted with kanamycin (1000 μg/ml) for strains carrying
pTCV-derived plasmids; erythromycin (5 μg/ml) and
chloramphenicol (10 μg/ml) for JHB11-derived strains, or
erythromycin (150 μg/ml) for the CL14 strain (Table 1).
E. coli strain DH5a was used as an intermediate host for
cloning and E. coli BL21 (DE3) was used for overproduc-
tion of His6-CcpA. E. coli strains were routinely grown
aerobically at 37°C in LB and transformed as previously
described [40]. Growth was monitored by measuring
absorbance at 600 nm in a Beckman DU640 spectrophot-
ometer. Aerobic growth was achieved by gyratory shaking
at 250 rpm. Ampicilin (100 μg/ml), erythromycin (150 μg/
ml) or kanamycin (50 μg/ml) was included in the medium
to select cells harboring ampicillin-, erythromycin- or
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Page 9 of 13kanamycin-resistant plasmids. 5-Bromo-4-chloro-3-indo-
lyl-b-D-galactopyranoside (20 μg/ml) (X-GAL) was used to
identify recombinant plasmids with DNA insertions that
impaired b-galactosidase activity in strain DH5a induced
with 0.5 mM IPTG.
Construction of plasmids with Pcit-lacZ transcriptional
fusions and b-galactosidase assays
The plasmids bearing the promoter-lacZ transcriptional
fusions, listed in Table 2, are all derivatives of the pTCV-
lac vector [26], and the oligonucleotides used in their con-
struction are also indicated in Table 2. In order to mutate
the cre2 site, the oligonucleotides EfHpromU-Cre2mut_Lo
and Cre2mut_Up-EfDpromL (Table 3) were used for the
amplification of two overlap extension PCR. These PCR
products were used as a DNA template for another PCR
using the oligonucleotides EfHpromU and EfDpromL, the
amplification products were cloned into the PCR-Blunt II-
TOPO vector. The cre3 site was mutated by following the
same protocol but using the oligonucleotides EfHpromU-
Cre3mut_Lo and Cre3mut_Up-EfDpromL (Table 3).
Deletion of cre1 was carried out by PCR using primers
EfbscitN and Efint_Lo. The pTOPO-derived plasmids
were digested with EcoRI and each released fragment was
ligated into the corresponding site of the pTCV-lac vector.
The desired orientation of the fragments was determined
by PCR. Cloned fragments were checked by sequencing at
the DNA sequencing Facility of the University of Maine,
USA.
Cells were grown overnight in LBC broth and different
carbon sources were added to the growth medium at the
specified concentrations as indicated in the figures or in
the text. Overnight cultures were diluted to an O.D.660 =
0.08 and grown in LB supplemented with a carbon
source until the cells reached early stationary phase. b-
Galactosidase activity was measured as described by
Israelsen et al. [41].
Protein purification and HPr phosphorylation
The gene encoding the transcriptional regulator CcpA
was amplified by PCR using genomic DNA from E. fae-
calis JH2-2 as the template, following a standard
Table 2 Plasmids used in this study
Plasmid Characteristics Oligonucleotides
† Reference or
source
pGh9 Thermosensitive plasmid carrying erythromycin resistance [46]
pGEM-T easy Promega
PCR-Blunt II-TOPO Invitrogen
pET28a Novagen
pBM02 pUC18 derivative carrying CRL264 replicon, Pcit (promoter) and chloramphenicol
resistance
[28]
pTCV-lac Promoterless vector which allows lacZ fusion construction [26]
pmCitO pGh9 derivative carrying a 500 bp citO internal fragment fcitOU, fcitOL [6]
pET-CcpA pET28a derivative expressing His6-CcpA Ef-ccpAU, Ef-ccpAL This study
pCitO pBM02 derivative for expressing CitO in E. faecalis [6]
pTCV-PcitHO EfHpromU,
EfDpromL
[6]
pTCV-PcitCL EfHpromU,
EfDpromL
[6]
pTCV-PcitHO-C1C2 EfHpromU,
EfbsPcitN
This study
pTCV-PcitHO-
C1C2M
EfHpromU,
EfbsPcitN
This study
pTCV-PcitHO-C2C3 EfbscitN, Efint_Lo This study
pTCV-PcitHO-
C2MC3
EfbscitN, Efint_Lo This study
pTCV-PcitHO-
C2C3M
EfbscitN, Efint_Lo This study
pTCV-PcitCL-C2C3 EfbscitN, Efint_Lo This study
pTCV-PcitCL-C2C3 EfbscitN, Efint_Lo This study
pTCV-PcitCL-
C2C3M
EfbscitN, Efint_Lo This study
pTCV-PcitCL-
C2MC3
EfbscitN, Efint_Lo This study
EfbscitN, Efint_Lo This study
†Oligonucleotide sequences are indicated in Table 3.
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Page 10 of 13protocol. The forward primer Ef-ccpAU introduced
a NdeI site around the initiation codon of the ccpA
gene, and the backward primer Ef-ccpAL introduced a
BamHI site downstream of the stop codon (Table 2 and
Table 3). The PCR product was double-digested and
ligated into the corresponding restriction sites of vector
pET-28a(+) (Novagen). The resulting plasmid, named
pET-CcpA, codes for CcpA extended with a 6-histidine
tag at the N terminus (Table 2). The correct sequence
of the insert was confirmed, and the plasmid was subse-
quently introduced into E. coli BL21 (DE3) for ccpA
overexpression.
E. coli BL21 (DE3) harboring the pET-ccpA plasmid was
g r o w ni nL Ba t3 7 ° Cu n t i la nO . D . 600= 0.6 was reached.
Next, CcpA expression was induced by addition of 0.5
mM IPTG. Following an overnight culture, cells were har-
vested by centrifugation and resuspended in ice-cold Tris-
HCl buffer (50 mM, pH 8.0), containing 1 mM phenyl-
methylsulfonyl fluoride, 1 mM dithiothreitol, 300 mM
NaCl and 5% glycerol. Cellsw e r ed i s r u p t e db yp a s s i n g
them through a French Pressure cell. The suspension was
centrifuged and the supernatant was mixed with nickel-
nitrilotriacetic acid agarose (Novagen). His6-CcpA was
eluted with imidazole and the purified protein was dia-
lyzed against binding buffer (25 mM Tris-HCl, pH 6.6,
150 mM NaCl and 10% glycerol) and stored at -80 °C for
further studies.
Lactobacillus casei HprK/P(V267F) and Enterococcus
casseliflavus HPr were overproduced using pQE30 vec-
tor and purified following a standard protocol, as
described previously [42].
Seryl-phosphorylated E. casseliflavus HPr was prepared
as described by Mazé et al. [43] using L. casei V267F
mutant HprK/P, which possesses kinase activity but has
almost completely lost the phosphorylase function [42].
About 0.5 mg of HPr was incubated for 30 min at 37°C
in 1 ml final volume containing also 10 μgo fH p r K / P
(V267F), 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2,1m M
fructose-1,6-bisphosphate (FBP), and 5 mM ATP. To
inactivate HprK/P(V267F), the samples were heated for
5 min at 75°C before they were desalted on PD-10 col-
umns (GE Healthcare Life Sciences) to remove ATP and
FBP and lyophilized. HPr and P-Ser-HPr were separated
by electrophoresis on nondenaturing 12.5% polyacryla-
mide gels and visualized by staining with Coomassie blue;
usually 99% of the HPr was converted into P-Ser-HPr.
DNA labeling
The synthetic oligonucleotides EfHpromU, Efint4_Lo,
EfbsPoadA were labeled at their 5’ ends using [g-
32P]
ATP (NEN PerkinElmer). The labeled oligonucleotides
were purified using a Zeba Desalt Spin Column
(Thermo scientific). DNA fragments containing different
cre sites were amplified by PCR; for the amplicons A, B
and C we used the primer pairs EfHpromU-EfcitNUp,
EfbscitN-Efint4_Lo and EfbsPoadA-Efbsint_Up, respec-
tively. Amplicon Bm was amplified with the primers
EfbscitN-Efint4_Lo using pTCV-PcitHO-C1C2M as tem-
plate and amplicon Cm with the primers EfbsPoadA-
Efbsint_Up using pTCV-PcitCL-C2C3M as template. The
amplicons were purified from a 2% agarose gel prior to
their use for binding reactions.
Gel mobility shift assays
Gel mobility assays were performed as follows. CcpA was
incubated with 5 μM HPr or P-Ser-HPr in the reaction
mix containing 10 mM Tris-HCl pH 7.5, 1 mM DTT, 1
mM EDTA, 50 mM KCl, 20 mM FBP, 0.05 mg/ml herring
DNA and 5% glycerol for 15 min at 37°C subsequently
DNA was added to the mixture reaching a final concentra-
tion of 0.1 nM. After incubation for another 15 min at
37°C, samples were loaded on a 5% polyacrylamide
gel. Gels were dried onto Whatman 3MM paper and
exposed to a storage phosphor screen, and band patterns
were detected in a GE Healthcare Life Sciences 840
Phosphorimager.
Citrate lyase activity
To determine citrate lyase activity, cultures of E. faecalis
JH2-2 and CL14 were grown for 7 hours in LB supplemen-
ted with 1% citrate and different glucose concentrations
(0.25, 0.5 and 1%). Cells were harvested and resuspended
in 200 μl of 100 mM phosphate buffer (pH 7.2) supple-
mented with 3 mM MgCl2 and 1 mM phenylmethylsulfo-
nyl fluoride. Total protein extracts were prepared by
treating the cells with 20 U/μl mutanolysin (Sigma) for 20
min at 37°C. Cells were then vortexed with glass beads
Table 3 Oligonucleotides used in this study
Oligonucleotides Sequences (5’-3’)
fcitOU GGAGAATTCAAACGGAACTTAG
fcitOL TTAACCAAGCTTCTTCTAGGGCAATAC
Ef-ccpAU GAAGCATATGGAAAAACAAACAATTACC
Ef-ccpAL GAATGGATCCTTATTTTGTTGAACC
EfHpromU AGAGGATTCATTACTAAAGATGTAAAC
EfDpromL CCATCTCGAGTAAATATTCTTTC
EfbsPcitN ATTGTCTCTCCTTTCACTAATTC
EfbscitN AAGCTAAAATAGTGAGTAACATG
Efint_Lo AAACGGAATTCTGGAAACTCTCC
Cre2mut_UP TACGATTGACACACCGGTGTTAATAAA
Cre2mut_Lo ACCGGTGTGTCAATCGTATAAAAAAGT
Cre3mut_Up GAGATTAATAAACGATTGATTCAACGTG
Cre3mut_Lo CACGTTGAATCAATCGTTTATTAATCTC
EfcitNUp GGGCCATATGTTACTCACTATTT
Efint4_Lo TTAGGCTATTTATTCTCTGCGAAAG
EfbsPoadA GAATTAGTGAAAGGAGAGACAAT
Efbsint_Up TATCCGCTTCACGTTGGATAAC
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Page 11 of 13(425-600 microns, Sigma) and cell debris was removed by
centrifugation. The assay mixture contained 100 mM
potassium phosphate buffer (pH 7.2), 5 mM trisodium
citrate, 3 mM MgCl2,0 . 2 5m MN A D H ,2 5Uo fm a l a t e
dehydrogenase (Sigma), and 20 or 40 μg of total protein
from different cell extracts in a final volume of 1 ml. Che-
mical acetylation of citrate lyase was performed by incubat-
ing protein extracts for 5 min at 25°C with 5 mM acetic
anhydride and then used immediately for determination of
citrate lyase activity. NADH oxidation was measured in a
spectrophotometer at 340 nm. One unit of enzyme activity
is defined as 1 pmol of citrate converted to acetate and
oxaloacetate per min under the conditions used [5].
Western blot analysis
E. faecalis strains JH2-2, JHB11 and CL14 were grown
individually at 37°C in LB medium supplemented with
1% citrate and different glucose concentrations (0.25, 0.5
and 1%). Cells were harvested by centrifugation and
crude extracts were prepared by vortexing cells with glass
beads (425-600 microns, Sigma). Proteins from cell
extracts were separated by sodium dodecyl sulfate-polya-
crylamide gel electrophoresis (SDS-PAGE) on a 12%
polyacrylamide gel and transferred to a nitrocellulose
membrane by electroblotting.
Proteins were detected with rabbit polyclonal antisera
raised against CitO of E. faecalis. Antibodies were visua-
lized by using goat anti-rabbit immunoglobulin G-AP sec-
ondary antibodies (Bio-Rad).
Analytical methods
Glucose concentrations were determined enzymatically
with a glucose oxidase-peroxidase based system following
the protocol provided by the supplier (Wiener Labs test
kit).
Acknowledgements
This work was supported by grants from the Agencia Nacional de
Promoción Científica y Tecnológica (PICT 2010-1828 and PICT 2008-1562;
Argentina) a European Union grant (BIAMFood, contract KBBE- 211441) and
MinCyt-ECOS collaboration program project number A09B03. C. S. is a fellow
of CONICET (Argentina), and V. B. and C. M. are Career Investigators from
CONICET (Argentina).
Author details
1Instituto de Biología Molecular y Celular de Rosario (IBR-CONICET),
Departamento de Microbiología, Facultad de Ciencias Bioquímicas y
Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, (S2002LRK)
Rosario, Argentina.
2Microbiologie de l’alimentation au service de la santé
humaine (MICALIS), INRA-AgroParisTech, 78850 Thiverval-Grignon, France.
3INRA-AgroParisTech, 78850 Thiverval-Grignon, France.
4CNRS, Micalis, F-
78350 Jouy-en-Josas, France.
Authors’ contributions
CAS carried out the molecular genetic studies, participated in the β-
galactosidase activities and protein purification. VSB carried out the
molecular genetic studies, participated in the band shift assay and helped to
draft the manuscript. SP participated in the purification of the proteins and
Band shift assay. JD participated in the coordination and helped to draft the
manuscript and CM participated in experiment design, coordination and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Received: 26 July 2011 Accepted: 11 October 2011
Published: 11 October 2011
References
1. Hugenholtz J: Citrate metabolism in lactic acid bacteria. FEMS Microbiol
Rev 1993, 12:165-178.
2. Giraffa G: Enterococci from foods. FEMS Microbiol Rev 2002, 26(2):163-171.
3. Mills D, Rawsthorne H, Parker C, Tamir D, Makarova K: Genomic analysis of
Oenococcus oeni PSU-1 and its relevance to winemaking. FEMS Microbiol
Rev 2005, 29(3):465-475.
4. Martin MG, Magni C, de Mendoza D, Lopez P: CitI, a Transcription Factor
Involved in Regulation of Citrate Metabolism in Lactic Acid Bacteria. J
Bacteriol 2005, 187(15):5146-5155.
5. Martin MG, Sender PD, Peiru S, de Mendoza D, Magni C: Acid-Inducible
Transcription of the Operon Encoding the Citrate Lyase Complex of
Lactococcus lactis Biovar diacetylactis CRL264. J Bacteriol 2004,
186(17):5649-5660.
6. Blancato VS, Repizo GD, Suarez CA, Magni C: Transcriptional Regulation of
the Citrate Gene Cluster of Enterococcus faecalis Involves the GntR
Family Transcriptional Activator CitO. J Bacteriol 2008, 190(22):7419-7430.
7. Sobczak I, Lolkema JS: The 2-Hydroxycarboxylate Transporter Family:
Physiology, Structure, and Mechanism. Microbiol Mol Biol Rev 2005,
69(4):665-695.
8. Martin M, Corrales M, de Mendoza D, Lopez P, Magni C: Cloning and molecular
characterization of the citrate utilization citMCDEFGRP cluster of
Leuconostoc paramesenteroides. FEMS Microbiol Lett 1999, 174(2):231-238.
9. Blancato V, Magni C, Lolkema J: Functional characterization and Me ion
specificity of a Ca-citrate transporter from Enterococcus faecalis. FEBS J
2006, 273(22):5121-5130.
10. Espariz M, Repizo G, Blancato V, Mortera P, Alarcon S, Magni C:
Identification of Malic and Soluble Oxaloacetate Decarboxylase Enzymes
in Enterococcus faecalis. FEBS J 2011.
11. Sender P, Martin M, Peiru S, Magni C: Characterization of an oxaloacetate
decarboxylase that belongs to the malic enzyme family. FEBS Lett 2004,
570(1-3):217-222.
12. Martin M, Magni C, Lopez P, de Mendoza D: Transcriptional Control of the
Citrate-Inducible citMCDEFGRP Operon, Encoding Genes Involved in
Citrate Fermentation in Leuconostoc paramesenteroides. J Bacteriol 2000,
182(14):3904-3912.
13. Foulquie Moreno M, Sarantinopoulos P, Tsakalidou E, De Vuyst L: The role
and application of enterococci in food and health. Int J Food Microbiol
2006, 106(1):1-24.
14. Sarantinopoulos P, Kalantzopoulos G, Tsakalidou E: Citrate Metabolism by
Enterococcus faecalis FAIR-E 229. Appl Envir Microbiol 2001,
67(12):5482-5487.
15. Rea M, Cogan T: Glucose prevents citrate metabolism by enterococci. Int
J Food Microbiol 2003, 88(2-3):201-206.
16. Deutscher J: The mechanisms of carbon catabolite repression in bacteria.
Curr Opin Microbiol 2008, 11(2):87-93.
17. Fujita Y: Carbon catabolite control of the metabolic network in Bacillus
subtilis. Biosci Biotechnol Biochem 2009, 73(2):245-259.
18. Galinier A, Deutscher J, Martin-Verstraete I: Phosphorylation of either crh
or HPr mediates binding of CcpA to the bacillus subtilis xyn cre and
catabolite repression of the xyn operon. J Mol Biol 1999, 286(2):307-314.
19. Schumacher M, Allen G, Diel M, Seidel G, Hillen W, Brennan R: Structural
basis for allosteric control of the transcription regulator CcpA by the
phosphoprotein HPr-Ser46-P. Cell 2004, 118(6):731-741.
20. Deutscher J, Pevec B, Beyreuther K, Kiltz H, Hengstenberg W: Streptococcal
phosphoenolpyruvate-sugar phosphotransferase system: amino acid
sequence and site of ATP-dependent phosphorylation of HPr.
Biochemistry 1986, 25(21):6543-6551.
21. Jia Z, Vandonselaar M, Quail J, Delbaere L: Active-centre torsion-angle
strain revealed in 1.6 A-resolution structure of histidine-containing
phosphocarrier protein. Nature 1993, 361(6407):94-97.
22. Audette G, Engelmann R, Hengstenberg W, Deutscher J, Hayakawa K,
Quail J, Delbaere L: The 1.9 A resolution structure of phospho-serine 46
HPr from Enterococcus faecalis. J Mol Biol 2000, 303(4):545-553.
Suárez et al. BMC Microbiology 2011, 11:227
http://www.biomedcentral.com/1471-2180/11/227
Page 12 of 1323. Hengstenberg W, Kohlbrecher D, Witt E, Kruse R, Christiansen I, Peters D,
Pogge von Strandm R, Stadtler P, Koch B, Kalbitzer H: Structure and
function of proteins of the phosphotransferase system and of 6-
phospho-beta-glycosidases in gram-positive bacteria. FEMS Microbiol Rev
1993, 12(1-3):149-163.
24. Kravanja M, Engelmann R, Dossonnet V, Bluggel M, Meyer H, Frank R,
Galinier A, Deutscher J, Schnell N, Hengstenberg W: The hprK gene of
Enterococcus faecalis encodes a novel bifunctional enzyme: the HPr
kinase/phosphatase. Mol Microbiol 1999, 31(1):59-66.
25. Reizer J, Bergstedt U, Galinier A, Kuster E, Saier M Jr, Hillen W, Steinmetz M,
Deutscher J: Catabolite repression resistance of gnt operon expression in
Bacillus subtilis conferred by mutation of His-15, the site of
phosphoenolpyruvate-dependent phosphorylation of the phosphocarrier
protein HPr. J Bacteriol 1996, 178(18):5480-5486.
26. Poyart C, Trieu-Cuot P: A broad-host-range mobilizable shuttle vector for
the construction of transcriptional fusions to beta-galactosidase in
gram-positive bacteria. FEMS Microbiol Lett 1997, 156(2):193-198.
27. Leboeuf C, Leblanc L, Auffray Y, Hartke A: Characterization of the ccpA
Gene of Enterococcus faecalis: Identification of Starvation-Inducible
Proteins Regulated by CcpA. J Bacteriol 2000, 182(20):5799-5806.
28. Marelli B, Magni C: A simple expression system for Lactococcus lactis and
Enterococcus faecalis. World J Microbiol Biotechnol 2010, 26(6):999-1007.
29. Opsata M, Nes I, Holo H: Class IIa bacteriocin resistance in Enterococcus
faecalis V583: the mannose PTS operon mediates global transcriptional
responses. BMC Microbiol 2010, 10:224.
30. Miwa Y, Nakata A, Ogiwara A, Yamamoto M, Fujita Y: Evaluation and
characterization of catabolite-responsive elements (cre) of Bacillus
subtilis. Nucleic Acids Res 2000, 28(5):1206-1210.
31. Schumacher MA, Sprehe M, Bartholomae M, Hillen W, Brennan RG:
Structures of carbon catabolite protein A-(HPr-Ser46-P) bound to diverse
catabolite response element sites reveal the basis for high-affinity
binding to degenerate DNA operators. Nucleic Acids Res 2011,
39(7):2931-2942.
32. Kim JH, Chambliss GH: Contacts between Bacillus subtilis catabolite
regulatory protein CcpA and amyO target site. Nucleic Acids Res 1997,
25(17):3490-3496.
33. Deutscher J, Francke C, Postma PW: How phosphotransferase system-
related protein phosphorylation regulates carbohydrate metabolism in
bacteria. Microbiol Mol Biol Rev 2006, 70(4):939-1031.
34. Zdobnov EM, Apweiler R: InterProScan - an integration platform for the
signature-recognition methods in InterPro. Bioinformatics 2001,
17(9):847-848.
35. Zeng L, Burne R: Seryl-phosphorylated HPr regulates CcpA-independent
carbon catabolite repression in conjunction with PTS permeases in
Streptococcus mutans. Mol Microbiol 2010, 75(5):1145-1158.
36. Stulke J, Arnaud M, Rapoport G, Martin-Verstraete I: PRD–a protein domain
involved in PTS-dependent induction and carbon catabolite repression
of catabolic operons in bacteria. Mol Microbiol 1998, 28(5):865-874.
37. Mehmeti I, Jonsson M, Fergestad EM, Mathiesen G, Nes IF, Holo H:
Transcriptome, Proteome, and Metabolite Analyses of a Lactate
Dehydrogenase-Negative Mutant of Enterococcus faecalis V583. Appl
Envir Microbiol 2011, 77(7):2406-2413.
38. Riboulet-Bisson E, Sanguinetti M, Budin-Verneuil A, Auffray Y, Hartke A,
Giard JC: Characterization of the Ers Regulon of Enterococcus faecalis.
Infect Immun 2008, 76(7):3064-3074.
39. Repizo G, Blancato V, Sender P, Lolkema J, Magni C: Catabolite repression
of the citST two-component system in Bacillus subtilis. FEMS Microbiol
Lett 2006, 260(2):224-231.
40. Sambrook J, Fritsch E, Maniatis T, (eds.): Molecular Cloning: a laboratory
manual. New York; 1989.
41. Israelsen H, Madsen S, Vrang A, Hansen E, Johansen E: Cloning and partial
characterization of regulated promoters from Lactococcus lactis Tn917-
lacZ integrants with the new promoter probe vector, pAK80. Appl Envir
Microbiol 1995, 61(7):2540-2547.
42. Monedero V, Poncet S, Mijakovic I, Fieulaine S, Dossonnet V, Martin-
Verstraete I, Nessler S, Deutscher J: Mutations lowering the phosphatase
activity of HPr kinase/phosphatase switch off carbon metabolism. EMBO
J 2001, 20(15):3928-3937.
43. Maze A, Boel G, Poncet S, Mijakovic I, Le Breton Y, Benachour A,
Monedero V, Deutscher J, Hartke A: The Lactobacillus casei ptsHI47T
Mutation Causes Overexpression of a LevR-Regulated but RpoN-
Independent Operon Encoding a Mannose Class Phosphotransferase
System. J Bacteriol 2004, 186(14):4543-4555.
44. Clewell DB, Tomich PK, Gawron-Burke MC, Franke AE, Yagi Y, An FY:
Mapping of Streptococcus faecalis plasmids pAD1 and pAD2 and
studies relating to transposition of Tn917. J Bacteriol 1982,
152(3):1220-1230.
45. Jacob AE, Hobbs SJ: Conjugal Transfer of Plasmid-Borne Multiple
Antibiotic Resistance in Streptococcus faecalis var. zymogenes. J Bacteriol
1974, 117(2):360-372.
46. Maguin E, Prevost H, Ehrlich S, Gruss A: Efficient insertional mutagenesis
in lactococci and other gram-positive bacteria. J Bacteriol 1996,
178(3):931-935.
doi:10.1186/1471-2180-11-227
Cite this article as: Suárez et al.: CcpA represses the expression of the
divergent cit operons of Enterococcus faecalis through multiple cre sites.
BMC Microbiology 2011 11:227.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Suárez et al. BMC Microbiology 2011, 11:227
http://www.biomedcentral.com/1471-2180/11/227
Page 13 of 13